Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Relapsing Remitting”

741 trials

Showing 20 of 741 results

Not applicableStudy completedNCT01564511
What this trial is testing

Effects of Electromechanical Gait Trainer in Patients With Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Universita di Verona 50
Very early researchUnknownNCT06039007
What this trial is testing

A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ospedale Policlinico San Martino 24
Large-scale testing (Phase 3)Study completedNCT02525874
What this trial is testing

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Biogen 218
Not applicableUnknownNCT04073940
What this trial is testing

Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Illinois at Urbana-Champaign 30
Post-approval studies (Phase 4)UnknownNCT02325440
What this trial is testing

Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University Hospital Muenster 15
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06223074
What this trial is testing

Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

Who this might be right for
Multiple Sclerosis Relapsing RemittingTreatment
Universidad Nacional Autonoma de Mexico 80
Not applicableWithdrawnNCT01071694
What this trial is testing

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer
Not applicableEnded earlyNCT05978531
What this trial is testing

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 25
Not applicableWithdrawnNCT01539395
What this trial is testing

A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MSDx, Inc.
Early research (Phase 1)UnknownNCT02903537
What this trial is testing

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Fundació Institut Germans Trias i Pujol 16
Testing effectiveness (Phase 2)Ended earlyNCT01226745
What this trial is testing

Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
EMD Serono 340
Not applicableStudy completedNCT01909492
What this trial is testing

Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Providence Health & Services 30
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Post-approval studies (Phase 4)Study completedNCT01585298
What this trial is testing

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6,998
Testing effectiveness (Phase 2)Active Not RecruitingNCT03846219
What this trial is testing

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Immunic AG 210
Early research (Phase 1)Study completedNCT00076934
What this trial is testing

Safety of RG2077 in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06700343
What this trial is testing

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen 152
Early research (Phase 1)Study completedNCT00837785
What this trial is testing

A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 48
Post-approval studies (Phase 4)Study completedNCT02373098
What this trial is testing

Fingolimod Effect on Cytokine and Chemokine Levels

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 126
Not applicableStudy completedNCT02914964
What this trial is testing

Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Terry L. Wahls 95
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation